1. Home
  2. OLMA vs RLTY Comparison

OLMA vs RLTY Comparison

Compare OLMA & RLTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • RLTY
  • Stock Information
  • Founded
  • OLMA 2006
  • RLTY 2022
  • Country
  • OLMA United States
  • RLTY United States
  • Employees
  • OLMA N/A
  • RLTY N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • RLTY Investment Managers
  • Sector
  • OLMA Health Care
  • RLTY Finance
  • Exchange
  • OLMA Nasdaq
  • RLTY Nasdaq
  • Market Cap
  • OLMA 299.7M
  • RLTY 255.5M
  • IPO Year
  • OLMA 2020
  • RLTY N/A
  • Fundamental
  • Price
  • OLMA $5.33
  • RLTY $15.30
  • Analyst Decision
  • OLMA Strong Buy
  • RLTY
  • Analyst Count
  • OLMA 4
  • RLTY 0
  • Target Price
  • OLMA $24.50
  • RLTY N/A
  • AVG Volume (30 Days)
  • OLMA 411.5K
  • RLTY 86.7K
  • Earning Date
  • OLMA 08-05-2025
  • RLTY 01-01-0001
  • Dividend Yield
  • OLMA N/A
  • RLTY 9.35%
  • EPS Growth
  • OLMA N/A
  • RLTY N/A
  • EPS
  • OLMA N/A
  • RLTY N/A
  • Revenue
  • OLMA N/A
  • RLTY N/A
  • Revenue This Year
  • OLMA N/A
  • RLTY N/A
  • Revenue Next Year
  • OLMA N/A
  • RLTY N/A
  • P/E Ratio
  • OLMA N/A
  • RLTY N/A
  • Revenue Growth
  • OLMA N/A
  • RLTY N/A
  • 52 Week Low
  • OLMA $2.86
  • RLTY $11.38
  • 52 Week High
  • OLMA $16.62
  • RLTY $14.60
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 66.85
  • RLTY 49.54
  • Support Level
  • OLMA $4.40
  • RLTY $15.22
  • Resistance Level
  • OLMA $5.36
  • RLTY $15.61
  • Average True Range (ATR)
  • OLMA 0.29
  • RLTY 0.21
  • MACD
  • OLMA 0.07
  • RLTY -0.02
  • Stochastic Oscillator
  • OLMA 93.20
  • RLTY 40.78

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About RLTY Cohen & Steers Real Estate Opportunities and Income Fund of Beneficial Interest

Cohen & Steers Real Estate Opportunities and Income Fund is an organized, non-diversified, closed-end management investment company. The Fund's primary investment objective is high current income. The Fund's secondary investment objective is capital appreciation.

Share on Social Networks: